comprehensive -WSS

comprehensive

author：leisure time 2025-10-06 12:34:50 Page View：2672

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Some dementia cases could be undiagnosed liver disease
Next article： The high cost of giving birth even with insurance

explore

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Novo Nordisk to expand supply of Wegovy for U.S. patients

BloombergphotobyGeorgeFreyLONDON—NovoNordisksaidWednesdaythatithadstartedtoincreasetheavailabilityof

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Congressmen charge Covid hearing ‘could have been an email’

Rep.BradWenstrup(R-Ohio)AnnaMoneymaker/GettyImagesWASHINGTON—HouseRepublicanshaverepeatedlyaccusedBi

comprehensive

focus

explore

Congressmen charge Covid hearing ‘could have been an email’